Zheng Quan Zhi Xing·2025-08-27 16:12Core Viewpoint - Qingdao Weilan Biological Co., Ltd. disclosed its major operational data for Q2 2025, highlighting significant revenue figures and changes in distributor numbers, which provide insights into the company's performance and market dynamics [1]. Group 1: Operational Performance - The total revenue for Q2 2025 amounted to CNY 255,554,845.37, with enzyme preparations contributing CNY 118,822,845.82 and micro-ecological preparations contributing CNY 62,179,855.65 [1]. - Direct sales accounted for CNY 171,922,085.69, while distribution sales totaled CNY 83,632,759.68 [1]. - Domestic sales reached CNY 224,210,819.54, while overseas sales were CNY 31,344,025.83 [1]. Group 2: Distributor Changes - The total number of distributors increased from 545 to 636 during the reporting period, indicating a growth in the distribution network [1]. - In Northeast China, the number of distributors rose from 31 to 38, while in North China, it increased from 60 to 76 [1]. - The East China region saw a significant increase from 304 to 331 distributors, while South China had a slight increase from 50 to 55 [1].